Kementrian Kesehatan Republik Indonesia. The Republic of Indonesia joint external monitoring mission for tuberculosis; 2020.

Salgame P, Geadas C, Collins L, Jones-López E, Ellner JJ. Latent tuberculosis infection - revisiting and revising concepts. Tuberculosis (Edinb) 2015;95:373–84. doi:10.1016/j.tube.2015.04.003.

Jeon CY, Murray MB. Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies. PLoS Med 2008;5:1091–101. doi: 10.1371/journal.pmed.0050152.

Kementerian Kesehatan Republik Indonesia. Indonesia National TB Program. Current status of integrated community based TB service delivery and the Global Fund work plan to find missing TB cases; 2018.

Ping PA, Zakaria R, Islam MA, et al. Prevalence and risk factors of latent tuberculosis infection (LTBI) in patients with type 2 diabetes mellitus (T2DM). Int J Environ Res Public Health 2021;18:305. doi: 10.3390/ijerph18010305.

Agha MA, Yousif M, Shehab-Eldin W, El-Helbawy NG, Moustafa RG, Sweed EM. Latent tuberculosis infection among patients with type 2 diabetes mellitus. Egypt J Chest Dis Tuberc 2020;69:277–83. DOI: 10.4103/ejcdt.ejcdt_85_19.

Lee MR, Huang YP, Kuo YT, et al. Diabetes mellitus and latent tuberculosis infection: a systemic review and metaanalysis. Clin Infect Dis 2017;64:719–27. doi: 10.1093/cid/ciw836.

van Crevel R, Dockrell HM; TANDEM Consortium. TANDEM: understanding diabetes and tuberculosis. Lancet Diabetes Endocrinol 2014;2:270-72. doi: 10.1016/S2213-8587(14)70011-7.

Koesoemadinata RC, McAllister SM, Soetedjo NNM, et al. Latent TB infection and pulmonary TB disease among patients with diabetes mellitus in Bandung, Indonesia. Trans R Soc Trop Med Hyg 2017;111:81–9. doi:10.1093/trstmh/trx015.

Leow MKS, Dalan R, Chee CBE, et al. Latent tuberculosis in patients with diabetes mellitus: prevalence, progression and public health implications. Exp Clin Endocrinol Diabetes 2014;122:528–32. doi: 10.1055/s-0034-1377044.

Workneh MH, Bjune GA, Yimer SA. Prevalence and associated factors of tuberculosis and diabetes mellitus comorbidity: a systematic review. PLoS One 2017;12:e0175925. doi: 10.1371/journal.pone.0175925.

Zheng C, Hu M, Gao F. Diabetes and pulmonary tuberculosis: a global overview with special focus on the situation in Asian countries with high TB-DM burden. Glob Health Action 2017;10:1264702. doi: 10.1080/16549716.2016.1264702.

Ernst JD. The immunological life cycle of tuberculosis. Nat Rev Immunol. 2012;12:581–91.

Wagnew F, Eshetie S, Alebel A, Dessie G, Tesema C, Abajobir AA. Meta-analysis of the prevalence of tuberculosis in diabetic patients and its association with cigarette smoking in African and Asian countries. BMC Res Notes 2018;11:1–7. https://doi.org/10.1186/s13104-018-3390-x.

Zhang H, Xin H, Li X, et al. A dose-response relationship of smoking with tuberculosis infection: a cross-sectional study among 21008 rural residents in China. PLoS One 2017;12: e0175183. doi:10.1371/journal.pone.0175183 .

Bai KJ, Lee JJ, Chien ST, Suk CW, Chiang CY. The influence of smoking on pulmonary tuberculosis in diabetic and non-diabetic patients. PLoS One 2016;11:e0156677. doi: 10.1371/journal.pone. 0156677.

Ruder K, Anthony R, Ogden A, Guthrie G, editors. American Diabetes Association Complete guide to diabetes. 5th ed. Alexandria, Virginia : American Diabetes Association;2011.

Martínez-Aguilar G, Serrano CJ, Castañeda-Delgado JE, et al. Associated risk factors for latent tuberculosis infection in subjects with diabetes. Arch Med Res 2015;46:221–7. doi: 10.1016/j.arcmed.2015.03.009.

Chen Z, Liu Q, Song R, et al. The association of glycemic level and prevalence of tuberculosis: a meta-analysis. BMC Endocr Disord 2021;21. https://doi.org/10.1186/s12902-021-00779-6.

Ye S, Ruan P, Yong J, Shen H, Liao Z, Dong X. The impact of HbA1c level of type 2 diabetics on the structure of haemoglobin. Sci Rep 2016;6:33352. doi: 10.1038/srep33352.

Abebe G, Bonsa Z, Kebede W. Treatment outcomes and associated factors in tuberculosis patients at Jimma University Medical Center: a 5-year retrospective study. Int J Mycobacteriol 2019;8:35-41. doi: 10.4103/ijmy.ijmy_177_18.

Gomez DI, Twahirwa M, Schlesinger LS, Restrepo BI. Reduced association of mycobacteria with monocytes from diabetes patients with poor glucose control. Tuberculosis (Edinb) 2013;93:192-7. doi:10.1016/j.tube.2012.10.003.

Lin CH, Kuo SC, Hsieh MC, et al. Effect of diabetes mellitus on risk of latent TB infection in a high TB incidence area: a community-based study in Taiwan. BMJ Open 2019;9:1–8. doi: 10.1136/bmjopen-2019-029948.

Chen C, Zhu T, Wang Z, et al. High latent TB infection rate and associated risk factors in the Eastern China of low TB incidence. PLoS One 2015;109. doi.: 10.1371/journal.pone.0141511.

Trollfors B, Sigurdsson V, Dahlgren-Aronsson A. Prevalence of latent TB and effectiveness of BCG vaccination against latent tuberculosis: an observational study. Int J Infect Dis 2021;109:279-82. https://doi.org/10.1016/j.ijid.2021.06.045.